Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography.
about
Role of cardiovascular magnetic resonance in acute coronary syndromePost myocardial infarction of the left ventricle: the course ahead seen by cardiac MRIContemporary cardiovascular imaging methods for the assessment of at-risk myocardium.T₂ -weighted MRI of post-infarct myocardial edema in mice.Towards stratifying ischemic components by cardiac MRI and multifunctional stainings in a rabbit model of myocardial infarction.Comparison of diffusion-weighted with T2-weighted imaging for detection of edema in acute myocardial infarction.Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion.Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection.Role of cardiovascular magnetic resonance in assessment of acute coronary syndrome.T2-weighted cardiovascular magnetic resonance in acute cardiac diseasePrediction of infarct severity from triiodothyronine levels in patients with ST-elevation myocardial infarctionDetermination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model.Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.Distinction of salvaged and infarcted myocardium within the ischaemic area-at-risk with T2 mapping.T2 mapping of the heart with a double-inversion radial fast spin-echo method with indirect echo compensation.Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols.Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications.T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patientsAutomatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT.Semi-automatic segmentation of myocardium at risk in T2-weighted cardiovascular magnetic resonance.Magnetic resonance imaging in the diagnostics of myocardial infarction.Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarctionQuantitative T 2* assessment of acute and chronic myocardial ischemia/reperfusion injury in miceCardiovascular magnetic resonance imaging of myocardial oedema following acute myocardial infarction: Is whole heart coverage necessary?The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial.Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction.Cardiac magnetic resonance imaging: A teaching atlas with emphasizing current clinical indications.Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled TrialsMagnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage.Cardiovascular magnetic resonance imaging of myocardial inflammation.Cardiac MRI in the treatment of arrhythmias.Quantification of myocardium at risk in ST- elevation myocardial infarction: a comparison of contrast-enhanced steady-state free precession cine cardiovascular magnetic resonance with coronary angiographic jeopardy scores.Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping.Evaluation of therapy management and outcome in Takotsubo syndrome.New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction.Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial.23Na chemical shift imaging and Gd enhancement of myocardial edema.Gadolinium can depict area at risk and myocardial infarction: a double-edged sword?Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease.
P2860
Q26771326-E94A483F-17DB-480D-9605-CB746BA636B6Q26849357-34E943A5-75BB-43FE-B576-196EEE089644Q27008874-10E1BF2B-31C1-4F55-B694-523BE6A96068Q30423185-7F575D47-F746-4CAD-BDBF-504AE0A2D1D8Q30444785-A47C5966-FF99-49D8-9F2C-238CF2A4F90CQ30671579-3EFFB67F-A1C0-41DD-AE4C-7F78FFCCED22Q31018147-DA351E21-F751-4DEF-A89B-4A0FFA5F9758Q33793245-D37EAFC3-6F3D-445C-AE97-F0667261ACE2Q33812907-66A33576-8441-448D-AEBE-4348EE13EB95Q33824106-36CD34B4-2A8E-48E2-BC52-840C1C99267FQ33912884-691286BF-BF6B-4F2D-860F-BDA7DCBB0144Q34004756-3E95D3BB-FB87-4E90-8D91-34D6605D7100Q34247485-7181895E-E14A-465C-AF22-F75EA72C5AEBQ34432749-61E0573C-39E2-4925-87D8-BF5F4834D6E0Q35118192-EB5EF3E6-CD0E-4D65-8373-B2A22B914540Q35252363-6589A1F4-6167-44F7-A4EC-A5BE9F9E5C7DQ35718217-F9FF1C4C-E535-4B48-8B07-8D79E4D82053Q35945907-64275728-8B74-440B-8F07-1A0DDA76D2B5Q35946709-CFEB84FE-EA68-4C77-8578-E3097035ECBBQ35951142-E85EAD6A-4867-477B-A97B-CA6DBE560FFEQ36076780-80067797-B143-4204-96E9-1CBE3B35EB08Q36247857-BAB1F478-E7BC-4073-B17C-5B3C09A00FCEQ36279421-9341AEF8-F4D5-4D13-BC89-9E911F481A13Q36494565-106B9F7B-2AEB-45A1-9F79-96DA66B3D614Q36809841-A1C172E8-4996-4255-9374-81CB7220D73BQ36819275-F9736501-0FF5-432A-B9EA-04BDE4455CAFQ37055876-D6C5029B-B67A-4194-BCE6-DBF4E79B8A4FQ37696752-53AA1DA2-2C59-4F5A-B279-7898C26AB304Q37912854-9F760CCE-B6D6-4787-A47F-F460F29AE5F6Q37935781-E4A65AC2-D171-445A-9D13-B7A6059AB673Q38124872-56931191-C821-49CA-B7DC-B8D7BDD3D5F1Q38373237-E667913C-01ED-42FE-BDF3-C339F5A6A42CQ38382606-319813A0-4D05-4CE4-8BB5-C3A13F4FCA21Q38400610-66293CCE-726C-4F31-BB69-140957132579Q38619641-489A03D9-2948-4A18-8C5B-2161946B868EQ38797894-9C16B887-EA68-47FC-9B13-B7ECCBB8937DQ39738896-D21FEDC5-5D35-441D-B4FC-690881157282Q42206024-B8286097-70BC-474B-A5A0-CFFCB67CF053Q42571665-05B6CCFB-8C14-4E19-B371-76538D091876Q42856665-FE62C736-E44A-4FA5-9C35-F0392F7694BC
P2860
Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Quantification of myocardial a ...... CMR and coronary angiography.
@en
Quantification of myocardial a ...... CMR and coronary angiography.
@nl
type
label
Quantification of myocardial a ...... CMR and coronary angiography.
@en
Quantification of myocardial a ...... CMR and coronary angiography.
@nl
prefLabel
Quantification of myocardial a ...... CMR and coronary angiography.
@en
Quantification of myocardial a ...... CMR and coronary angiography.
@nl
P2093
P1476
Quantification of myocardial a ...... CMR and coronary angiography.
@en
P2093
Jan Bogaert
Jeremy Wright
Steven Dymarkowski
Tom Adriaenssens
Walter Desmet
P304
P356
10.1016/J.JCMG.2009.02.011
P577
2009-07-01T00:00:00Z